Sunshine Biopharma (Sunshine Biopharma) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma ROE % Adjusted to Book Value?

Sunshine Biopharma's ROE % for the quarter that ended in Mar. 2024 was -22.32%. Sunshine Biopharma's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Sunshine Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Sunshine Biopharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Sunshine Biopharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma ROE % Adjusted to Book Value Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Sunshine Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sunshine Biopharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunshine Biopharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sunshine Biopharma's ROE % Adjusted to Book Value falls into.

Sunshine Biopharma ROE % Adjusted to Book Value Calculation

Sunshine Biopharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-21.04%	/	N/A
	=	N/A

Sunshine Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-22.32%	/	N/A
	=	N/A

Sunshine Biopharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma (Sunshine Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).